GAGLIARDI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 510
EU - Europa 166
AS - Asia 27
Totale 703
Nazione #
US - Stati Uniti d'America 505
IT - Italia 87
DE - Germania 23
CN - Cina 22
PL - Polonia 20
GB - Regno Unito 11
SE - Svezia 10
FI - Finlandia 7
CA - Canada 5
UA - Ucraina 3
HK - Hong Kong 2
IE - Irlanda 2
VN - Vietnam 2
BG - Bulgaria 1
DK - Danimarca 1
IN - India 1
NL - Olanda 1
Totale 703
Città #
Chandler 127
Fairfield 45
Ashburn 41
Milan 29
Addison 23
Bremen 21
Princeton 21
Shanghai 21
Warsaw 20
Ferrara 19
Seattle 15
Cambridge 14
New York 14
Houston 12
Wilmington 12
San Diego 10
Bologna 9
Woodbridge 9
Ann Arbor 7
Casalecchio Di Reno 7
Helsinki 6
London 6
Treviso 4
Chicago 3
Ferrara di Monte Baldo 3
Toronto 3
Voghera 3
Washington 3
Des Moines 2
Dong Ket 2
Falls Church 2
Hong Kong 2
Leawood 2
Norwalk 2
Ottawa 2
Redwood City 2
San Mateo 2
Turin 2
Amsterdam 1
Boydton 1
Gambettola 1
Hangzhou 1
Huskvarna 1
Hyde 1
Lappeenranta 1
Manchester 1
Monmouth Junction 1
Mountain View 1
Odesa 1
Olbia 1
Poggio Renatico 1
Salerno 1
Sofia 1
Southwark 1
Stockholm 1
Wembley 1
Totale 545
Nome #
Functional hypothalamic and drug-induced amenorrhea: an overview 79
A tool to predict survival in stage IV entero-pancreatic NEN 60
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 46
Challenges in metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) in well differentiated G1 primitive tumors 45
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 37
Acromegaly in the elderly patients 34
Hypeprolactinemia: still an insidious diagnosis 33
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 30
Bone health in adolescence 30
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 29
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 28
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 26
The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major 23
Iperprolattinemia: vecchie e nuove insidie diagnostiche 22
L’acromegalia nell’anziano 20
Craniopharyngioma and Eating Disorders 20
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 20
I livelli di colesterolo LDL sono associati alla secrezione insulinica 20
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 19
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy 18
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 17
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 15
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 15
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 14
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life 13
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia 13
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 12
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 9
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 8
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 7
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance 5
Evaluation of new prognostic tools for neuroendocrine tumors: from clinical scores to genetic profiling 5
Long-term low-dose tolvaptan efficacy and safety in SIADH 5
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4) 5
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 4
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 3
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 3
Effetto del diabete sulla morbilità e mortalità in pazienti con acromegalia 2
Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly 2
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 1
Marcatori prognostici nelle neoplasie neuroendocrine (NEN) 1
Totale 798
Categoria #
all - tutte 7.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 251
Totale 8.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 1 2 4 6 4 4 6 4 4 0 2 0
2020/202192 0 11 1 9 11 5 4 9 9 18 8 7
2021/2022166 9 4 1 2 11 10 8 16 6 6 8 85
2022/2023309 23 56 15 32 34 26 38 30 26 4 19 6
2023/2024194 12 24 15 10 16 47 13 27 26 4 0 0
Totale 798